Filing Details
- Accession Number:
- 0001127602-14-001333
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-01-06 18:27:09
- Reporting Period:
- 2013-12-20
- Filing Date:
- 2014-01-06
- Accepted Time:
- 2014-01-06 18:27:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 850693 | Allergan Inc | AGN | Pharmaceutical Preparations (2834) | 951622442 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1298941 | M Scott Whitcup | 2525 Dupont Drive Irvine CA 92612 | Executive Vp, R&D, Cso | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-12-20 | 16,500 | $0.00 | 33,827 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-12-20 | 16,500 | $107.80 | 17,327 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-12-20 | 16,500 | $0.00 | 33,827 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-12-20 | 16,500 | $109.80 | 17,327 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2013-12-20 | 16,500 | $0.00 | 16,500 | $36.15 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2013-12-20 | 16,500 | $0.00 | 16,500 | $36.15 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 40,700 | 2015-02-08 | No | 4 | M | Direct | |
| 24,200 | 2015-02-08 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,707 | Indirect | By 401(k) |
| Common Stock | 1,739 | Indirect | By Esop |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2012.
- Shares allocated to reporting person's SIP account as of reporting date.
- Shares allocated to the reporting person's ESOP account as of reporting date.
- The option becomes exercisable in four equal annual installments beginning February 9, 2006.
Billionaire Hedge Funds
